NCAB Cancer Centers committee recommends Ratio Cap To Limit Growth of Largest Grants
In Brief: House Hearing On NCI Budget Is March 16; NIH Reauthorization Sent To Senate Floor
NCI Critic Epstein Resurfaces TO Blast ‘Cancer Establishment’
NCAB Oks LANs To Links NCI Staff With Each Other, The World
“We’d Ban Cigarettes’ If Nicotine Were a Drug, FDA Commissioners Says
NIAID Advisors Ok Recompetition of Pediatric ACTGs
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ - One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- NCI’s Philip Castle on NHS-Galleri results: “I’m sorry that it didn’t work, but it keeps the national conversation going.”
Castle is “disappointed” by Galleri results but not discouraged by implications for MCDs
